Site Management Organization
We manage the sites.
You get the data.
Premier Bioservices activates and runs studies across a managed network of clinics, practices, and health systems — then keeps patients engaged between visits with a dedicated team of clinical nurses working remotely. One partner. Every site. Wherever the patient is.
- 20+ years in clinical research
- Multi-site network model
- Remote clinical nurse monitoring
- Wound care depth
- FDA decentralized-elements aligned
- ICH E6(R3) ready
The problem we were built for
Most studies do not fail on science. They fail on sites.
Sponsors consistently name the same friction: too many competing trials at a site, thin recruitment infrastructure, and contracting that stalls before the first patient is ever screened. An SMO exists to take all three off your desk.
Patients enrolled per site per month in US diabetic foot ulcer trials — with a median of just 0.58. Non-US sites outperform them, and trials that spread across more sites enroll materially faster.
Systematic review of 397 DFU trials, 31,955 participants
Of sponsors name competing trials and lack of site attention as their single biggest pain point, followed by weak recruitment processes at 25% and contracting delays at 19%.
ISR Reports, Site Networks Market Dynamics
Of sponsors and CROs say they are likely to use site networks to recruit sites for upcoming trials. Three in four already do.
ISR Reports, 2026
An SMO is the structural answer. One partner absorbs feasibility, contracting, regulatory, training, monitoring, and reporting across every site — so the variability that usually shows up in your timeline never reaches it.
Who we work with
Three relationships, one operating layer.
Sponsors need predictability. Providers need the burden removed. Health systems need capacity without overhead. The same infrastructure serves all three.
Our flagship capability
A clinical nursing team that follows the patient, not the calendar.
Approval is not the finish line and enrollment is not the whole job. Whatever a study needs between visits — for twelve weeks or for five years, before approval or long after it — we staff it with licensed clinical nurses working under investigator oversight.
Telehealth and in-home visits
Protocol-driven follow-up conducted by trial personnel remotely or in the participant's home, consistent with FDA's guidance on trials with decentralized elements.
Longitudinal patient follow-up
Scheduled nurse contact across the full follow-up window, from 12-week wound healing endpoints through multi-year registry and post-market commitments.
Remote data and imaging review
Digital health technologies, ePRO capture, and remote wound imaging reviewed by clinical staff so a stalling wound gets escalated in days, not at the next monthly visit.
Centralized monitoring and oversight
Risk-based quality management with pre-specified tolerance limits, documented escalation pathways, and an auditable record of who reviewed what and when.
- Of trial cost is on-site monitoring
- 30%Of trial cost is on-site monitoringShifting verification to remote review is one of the largest single cost levers available to a sponsor.
- FDA final DCT guidance
- 2024FDA final DCT guidanceTelehealth visits, in-home visits, and local healthcare providers are explicitly permitted trial elements.
- The new GCP baseline
- E6(R3)The new GCP baselineQuality by design, critical-to-quality factors, and risk-proportionate centralized oversight.
- Escalation pathway
- 24/7Escalation pathwayDefined routes for adverse events and safety signals, with the investigator in the loop.
Therapeutic expertise
Depth where it counts, breadth where it helps.
We do not claim every indication. Our network is built around populations we can genuinely reach — with wound care as the area we know best.
How an engagement runs
Four steps from protocol to close-out.
The sequence is deliberately boring. Predictability is the product.
- 01
Feasibility and site matching
We read the protocol against the network: which sites hold the right patient population, which investigators have the relevant experience, and where the inclusion criteria will realistically bind. You get an honest enrollment projection rather than an optimistic one.
- 02
Startup and activation
Master agreement, budget negotiation, IRB and regulatory submission, delegation logs, and site training run in parallel rather than in series. Standardized documents mean the second site activates far faster than the first.
- 03
Conduct and remote follow-up
Coordinators run visits at the site. Our clinical nurses run everything between them: telehealth check-ins, ePRO and imaging review, adherence and retention contact, and safety escalation on a defined pathway.
- 04
Oversight, reporting, and close-out
Centralized monitoring against pre-specified quality tolerance limits, portfolio-level enrollment and performance reporting, query resolution, and a documented trail that holds up under inspection.
Who you will work with
Two decades of research and healthcare operations, on your study.
Premier Bioservices is led by a research scientist who has built protocols, biorepositories, and regulatory submissions inside academic medical centers, and a healthcare CFO who has run the finances of acute care hospitals and physician groups. Study design and study economics, in the same room.
- Protocol design, biobanking, and academic research operations
- Regulatory submission and IRB process experience
- Healthcare finance leadership at CFO level
- Budget negotiation that funds every protocol requirement
- Twenty-plus years across pharmaceutical and medical product trials
- Dozens of studies across academic, community, and health system settings
Start a conversation
Tell us about the study. We will tell you what the network can do.
Send a protocol synopsis or a feasibility questionnaire and we will come back with site capacity, an honest enrollment projection, and where decentralized elements would reduce burden.